The global digital therapeutics market is expected to grow from USD 2,462.27 million 2017 to USD 7,635.55 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 17.55%.

On the basis of indication, the global digital therapeutics market is studied across Cardiovascular Diseases, Central Nervous System (CNS) Disorders, Chronic Respiratory Diseases (CRD), Diabetes, Medication Adherence, Musculoskeletal Disorders, Obesity, Prediabetes, and Smoking Cessation.

On the basis of sales channel, the global digital therapeutics market is studied across B2B and B2C.

On the basis of geography, the global digital therapeutics market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).

"2morrow Inc.: The potential growing player for the global digital therapeutics market"

The key players profiled in the global digital therapeutics market are 2morrow Inc., Canary Health Inc., Ginger.Io, Inc., Livongo Health, Mango Health Inc., Noom Inc., Omada Health, Inc., Propeller Health, Proteus Digital Health, Inc., and Welldoc, Inc..


The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global digital therapeutics market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global digital therapeutics market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global digital therapeutics market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global digital therapeutics market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global digital therapeutics market.